Publicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (8)

2021

  1. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review

    Current Research in Translational Medicine

2019

  1. Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

    Biology of Blood and Marrow Transplantation, Vol. 25, Núm. 5, pp. 1022-1030

  2. Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma

    Annals of Hematology

  3. Pharmacokinetic/Pharmacodynamic Analysis of Voriconazole Against Candida spp. and Aspergillus spp. in Allogeneic Stem Cell Transplant Recipients

    Therapeutic Drug Monitoring, Vol. 41, Núm. 6, pp. 740-747

2018

  1. Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation

    American Journal of Transplantation, Vol. 18, Núm. 12, pp. 2885-2894

2013

  1. Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

    Biology of Blood and Marrow Transplantation, Vol. 19, Núm. 1, pp. 69-74

2011

  1. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

    Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16

2009

  1. Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: A phase II trial

    Leukemia and Lymphoma, Vol. 50, Núm. 2, pp. 216-222